Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 4 of 24, showing 5 Applications out of 118 total, starting on record 16, ending on 20

# Protocol No Study Title Investigator(s) & Site(s)

16.

ECCT/23/06/02   IMAGINE-TBM
    A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis: Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM).   
Principal Investigator(s)
1. Deborah Chepng\'eno Langat
Site(s) in Kenya
KEMRI/WRP CRC
 
View

17.

ECCT/23/10/07   Fermented Food and Prediabetes
        A Study of the Hypoglycemic Effect of African Traditonal Fermented Foods amongst Prediabetic Adults.   
Principal Investigator(s)
1. Rosebella Iseme - Ondiek
Site(s) in Kenya
1. Aga Khan Outreach Centre Nairobi CBD/Town (Nairobi City county)
2. Aga Khan Outreach Centre Valley Arcade (Nairobi City county)
3. Aga Khan Outreach Centre Capital Centre (Nairobi City county)
4. Aga Khan Outreach Centre Kiambu Town (Kiambu county)
5. Aga Khan Outreach Centre Juja (Kiambu county)
6. Aga Khan Outreach Centre Ruiru (Kiambu county)
7. Aga Khan Outreach Centre Ongata Rongai (Kajiado county)
8. Aga Khan Outreach Centre Ngong (Kajiado county)
9. Aga Khan Outreach Centre Kitengela (Kajiado county)
 
View

18.

ECCT/23/05/02   A5384
    A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis: Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
View

19.

ECCT/23/05/01   A5356
    A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination with a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTRE
 
View

20.

ECCT/23/03/07   PLATINUM STUDY
    (PLATINUM): A multi-part, multi-center PLATform study to assess the efficacy, safety, tolerability and pharmacokinetics of anti-malarial agents administered as monotherapy and/or combination therapy IN patients with Uncomplicated Plasmodium falciparum Malaria   
Principal Investigator(s)
1. Godfrey (Site 5001) Allan Otieno
2. Bernhard Ragama Ogutu
3. John (Site 5002) Orimbo
Site(s) in Kenya
1. KEMRI Kondele Children Hospital (Kisumu county)
2. AHERO CLINICAL TRIALS UNIT (Kisumu county)
 
View